Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
ATM deletion
i
Other names:
ATM, ATA, ATC, ATD, ATDC, TEL1, TELO1, ATM serine/threonine kinase
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
472
Related biomarkers:
Expression
Mutation
Others
‹
›
Associations
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
ATM deletion
Mantle Cell Lymphoma
ATM deletion
Mantle Cell Lymphoma
VP-006
Sensitive: D – Preclinical
AACR 2023 - 2 weeks (New D)
VP-006
Sensitive
:
D
AACR 2023 - 2wk
VP-006
Sensitive: D – Preclinical
AACR 2023 - 2 weeks
VP-006
Sensitive
:
D
AACR 2023 - 2 weeks - (New D)
ATM deletion
Mantle Cell Lymphoma
ATM deletion
Mantle Cell Lymphoma
ART558
Sensitive: D – Preclinical
AACR 2023 - 2 weeks (New D)
ART558
Sensitive
:
D
AACR 2023 - 2wk
ART558
Sensitive: D – Preclinical
AACR 2023 - 2 weeks
ART558
Sensitive
:
D
AACR 2023 - 2 weeks - (New D)
ATM deletion
Small Cell Lung Cancer
ATM deletion
Small Cell Lung Cancer
olaparib
Sensitive: C2 – Inclusion Criteria
olaparib
Sensitive
:
C2
olaparib
Sensitive: C2 – Inclusion Criteria
olaparib
Sensitive
:
C2
ATM deletion
Solid Tumor
ATM deletion
Solid Tumor
BAY 1895344
Sensitive: C2 – Inclusion Criteria
BAY 1895344
Sensitive
:
C2
BAY 1895344
Sensitive: C2 – Inclusion Criteria
BAY 1895344
Sensitive
:
C2
ATM deletion
Colorectal Cancer
ATM deletion
Colorectal Cancer
M6620
Sensitive: C3 – Early Trials
M6620
Sensitive
:
C3
M6620
Sensitive: C3 – Early Trials
M6620
Sensitive
:
C3
ATM deletion
Prostate Cancer
ATM deletion
Prostate Cancer
olaparib
Sensitive: C3 – Early Trials
olaparib
Sensitive
:
C3
olaparib
Sensitive: C3 – Early Trials
olaparib
Sensitive
:
C3
ATM deletion
Lung Adenocarcinoma
ATM deletion
Lung Adenocarcinoma
olaparib + VE-821
Sensitive: D – Preclinical
olaparib + VE-821
Sensitive
:
D
olaparib + VE-821
Sensitive: D – Preclinical
olaparib + VE-821
Sensitive
:
D
ATM deletion
Squamous Cell Carcinoma of Head and Neck
ATM deletion
Squamous Cell Carcinoma of Head and Neck
olaparib + AZD7648
Sensitive: D – Preclinical
olaparib + AZD7648
Sensitive
:
D
olaparib + AZD7648
Sensitive: D – Preclinical
olaparib + AZD7648
Sensitive
:
D
ATM deletion
Solid Tumor
ATM deletion
Solid Tumor
PLX038
Sensitive: D – Preclinical
PLX038
Sensitive
:
D
PLX038
Sensitive: D – Preclinical
PLX038
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login